Trial
NCT03026231
Characterization of Fecal Microbiome Changes After Administration of PRIM-DJ2727 in Parkinson's Disease Patients
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
The University of Texas Health Science Center, Houston
Collaborators
Kelsey Research Foundation
Condition
Parkinson's Disease
Intervention
PRIM-DJ2727
Why stopped
study will be started under a new modified protocol
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-08-10